Markets
Tendies
@tendies
Bought INBS
Shares
down -5.37%
At 2.24, Exited 2.12
I just bought into INBS because the imminent FDA decision is just a week away and the company is showing solid potential with its unique fingerprint s...
Read
More
Thesis
I just bought into INBS because the imminent FDA decision is just a week away and the company is showing solid potential with its unique fingerprint sweat drug testing. Coupled with substantial revenue growth and the strong clinical data backing them up, I believe there’s a great chance for a price surge soon.
Go back
Tendies
@tendies
Bought INBS
Shares
up 18.27%
At 1.97, Exited 2.33
I just bought some shares of INBS because their patented drug detection kit is a game changer with FDA approval around the corner. With a small float ...
Read
More
Thesis
I just bought some shares of INBS because their patented drug detection kit is a game changer with FDA approval around the corner. With a small float and potential for big contracts or even a buyout, I think this stock could skyrocket to $11-$25+ after the FDA response.
Go back
Tendies
@tendies
Bought INBS
Shares
down -16.33%
At 2.51, Exited 2.1
I'm really bullish on $INBS because their innovative drug testing tech has huge potential. With solid revenue growth and upcoming FDA approval in 2025...
Read
More
Thesis
I'm really bullish on $INBS because their innovative drug testing tech has huge potential. With solid revenue growth and upcoming FDA approval in 2025, I see this stock climbing significantly, especially given its small market cap and increasing customer base. I'm holding on to my shares for the ride ahead.
Go back
The
@themarke...
Bought INBS
Shares
up 34.59%
At 1.85, Exited 2.49
I'm really excited about INBS, especially with its upcoming FDA approval for the rapid drug testing device. This innovation could change the game for ...
Read
More
Thesis
I'm really excited about INBS, especially with its upcoming FDA approval for the rapid drug testing device. This innovation could change the game for drug testing, and with the growing need for quick results, I believe it’s a promising investment for the future.
Go back
Tendies
@tendies
Bought INBS
Shares
up 13.19%
At 1.44, Exited 1.63
I'm really bullish on INBS right now. With FDA submission just around the corner and a strong market for their innovative drug testing technology, I b...
Read
More
Thesis
I'm really bullish on INBS right now. With FDA submission just around the corner and a strong market for their innovative drug testing technology, I believe this stock can soar. The potential is huge, especially after they get FDA clearance and expand in the U.S. market.
Go back
Tendies
@tendies
Bought INBS
Shares
up 14.09%
At 1.49, Exited 1.7
I just bought shares of INBS because with their FDA submission coming soon and solid financials, I believe the stock is significantly undervalued. The...
Read
More
Thesis
I just bought shares of INBS because with their FDA submission coming soon and solid financials, I believe the stock is significantly undervalued. The patented fingerprint drug test is a game changer, and I expect a big price pop when the news drops and growth to continue afterward.
Go back
Tendies
@tendies
Bought INBS
Shares
up 8.74%
At 2.06, Exited 2.24
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw sign...
Read
More
Thesis
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw significant volume and breakout potential around the 50 DMA, so I'm looking for a solid upside as it enters the US market.
Go back
Tendies
@tendies
Bought INBS
Shares
up 8.74%
At 2.06, Exited 2.24
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, an...
Read
More
Thesis
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, and with the market cap under $5 million, I'm convinced this could have a strong week ahead.
Go back
